about CIGX in www.smallcapnetwork.comFrom www.smallcapnetwork.com
''First up this morning is Star Scientific Inc., (CIGX) https://www.starscientific.com/ currently 
in the $2.67 range. CIGX was trading between $4 and $5 a year ago before it plunged in June of 09 to $1. CIGX kept a one dollar floor for 8-Months until it rallied this month taking it back into the $3 level. CIGX has a 52-week high of $5.89 set on 05-29-09 with current trailing twelve month revenues of $728+ million. CIGX is a near-term (3 Mo) ‘Buy’ consideration for me. It is priced at less than half its high and has a rally going on. There are a few more shorters of the than I like, but I don’t belive that there is enough downward pressure to hold back the stocks current climb.
Last month, CIGX filed an application with the FDA for approval to market as a “modified risk” tobacco product under the Family Smoking Prevention and Tobacco Control Act of 2009. This submission is the first such application to be filed with the Tobacco Products Center of the FDA, which has been established to oversee all aspects of tobacco regulation outlined in the 2009 Act.
Ariva is a dissolvable tobacco lozenge with wintergreen flavoring, is made with flue-cured tobacco that contains levels of tobacco-specific nitrosamines (TSNAs) that are below detectable limits by most current standards of measure. TSNAs have been identified in scientific literature since the early 1950s as one of the most deadly and abundant groups of carcinogens in tobacco and its smoke. CIGX makes, sells, and licenses tobacco curing technology that prevents the formation of carcinogenic toxins present in tobacco and tobacco smoke, primarily the tobacco-specific nitrosamines (TSNA).''